yahoo

Wall St. mixed as earnings offset merger news

Traders work on the floor of the New York Stock Exchange April 20, 2015.Reuters/Brendan McDermid n”>(Reuters) – U.S. stocks were mixed on Tuesday, with the Dow industrials pulled down by a handful of uninspiring earnings reports, while the Nasdaq was pushed higher by a proposed biotech merger.Travelers (TRV.N), DuPont (DD.N) and IBM (IBM.N) shares weighed most on the Dow. DuPont […]

Earnings gusher is next test for stocks after market wipeout

But 53 percent of companies have so far missed their revenue forecasts. The industrial sector could come under special scrutiny in the coming week because of high-profile revenue misses Friday by both General Electric and Honeywell.”I think you’ll continue to see a pullback, and I think the industrial angle is going to be a good one because industrials are going […]

Etsy starts trading on the Nasdaq at $31 per share — nearly double …

Want to master the CMO role? Join us for GrowthBeat Summit on June 1-2 in Boston, where we’ll discuss how to merge creativity with technology to drive growth. Space is limited and we’re limiting attendance to CMOs and top marketing execs. Request your personal invitation here!
Etsy began trading on the Nasdaq at $31.86 a share — a big pop from the $16 a share price the company set […]

A Buyback or Biotech Bubble?

Steven Davidoff Solomon, professor of law at the University of California, Berkeley, wrote a comment for the New York Times reports, General Motors’ Stock Buyback Follows a Worrying Trend:
General Motors’ announcement that it will buy back $5 billion worth of stock raises the question of whether the stock buyback has turned into a shareholder activist shakedown.G.M. did not open its […]

Is The Biotech Stock Correction A Buying Opportunity Or A Wake Up Call?

Disclosure: I own shares of AMGN and GILDBiotechnology stocks have been in a sharp correction this week. The iShares Nasdaq Biotechnology ETF dropped close to one-percent in early Thursday trade, following a 1.89% decline on Wednesday; and the SPDR S&P biotech ETF registered similar losses.Is the correction a buying opportunity or a wake up call?Both.On the one side, the correction […]

Biotech, real estate and Greece: What to watch today

Welcome to Friday. Here are three things to keep an eye on during the trading day.Two of today’s three are animated by near-opposite human cravings, but both have been crucial drivers of this bull market: biotech stocks and REITs.Number 1:Biotechs are all about a hoped-for future, the promised huge payoff from smarts and risk-taking, magic molecules to extend lives and […]

5 Stocks With 30+ Percent Upside in 2015

I’ve read an interesting article on CNN Money, called: 7 stocks Wall Street thinks will soar this year.The author introduced seven stocks about which the Wall-Street guys seeing good upside potential this year.Normally, I don’t care about those articles, especially when I see that Tesla, Facebook or some Biotech’s are recommend but this time, I agree with five stocks from […]

The Seven Financial Indicators of Highly Successful Biotech Stocks …

The Seven Financial Indicators of Highly Successful Biotech Stocks InvestingCompanies / BioTechFeb 21, 2015 – 10:41 AM GMTBy: Money_MorningErnie Tremblay writes: When evaluating biotech stocks, many key indicators that work for other industries – e.g. price-to-earnings ratio, profit margin, revenue-per-share – often don’t apply.Here’s why they don’t, and why seven of these critical financial indicators do…The Usual Ratios Don’t ApplyThe […]

Biotechs soar in premarket; many have strong drug data

Biotechs soar in premarket; many have strong drug data – Yahoo News

Follow Yahoo News


on Facebook


on Tumblr


on Google+

on Flickr

Follow live:
Police continue hunt for Charlie Hebdo suspects in France
By Ryan Vlastelica 14 minutes ago

Content preferencesDone

Original post:

Biotechs soar in premarket; many have strong drug data
 […]

No, that high school kid didn't make $72 million trading stocks

You may have seen the amazing story today about the high school kid who made $72 million trading stocks. There were plenty of red flags in the original New York Magazine article. But now CNBC is reporting that the $72 million figure is totally bogus.Mohammed Islam, a 17-year-old high school kid in New York, was profiled as a Wall Street […]